USTEKINUMAB IMPROVES HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MODERATE-TO-SEVERE CROHN’S DISEASE: RESULTS UP TO WEEK 104 OF THE STARDUST TRIAL

Laurent Peyrin-Biroulet  ¹     Severine Vermeire  ²     Geert R. D'Haens  ³     Julian Panés  ⁴     Axel Dignass  ⁵     Fernando Magro  ⁶     Maciej Nazar  ⁷     Manuela Le Bars  ⁸     Marjolein Lahaye  ⁹     Lioudmila Ni  ¹⁰     Ivana Bravatà  ¹¹     Daniel R. Gaya  ¹²     Silvio Danese  ^13    
1 University Hospital of Nancy, University of Lorraine, Houdemont, France
² University Hospitals Leuven, Leuven, Belgium
³ University of Amsterdam, Academic Medical Center, Amsterdam, Netherlands
⁴ Hospital Clinic of Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain
⁵ Agaplesion Markus Hospital, Goethe University, Frankfurt/ Main, Germany
⁶ Hospital de São João, Porto, Portugal
⁷ Janssen-Cilag Polska Sp. z .o.o, Warsaw, Poland
⁸ Janssen-Cilag, Issy Les Moulineaux, France
⁹ Janssen-Cilag BV, Breda, Netherlands
¹⁰ Janssen-Cilag Russia, Moscow, Russian Federation
¹¹ Janssen-Cilag, Milan, Italy
¹² Glasgow Royal Infirmary, Glasgow, United Kingdom
¹³ IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milan, Italy

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)